Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tobramycin once vs three times daily in febrile neutropenia
NCT00257790Phase 4Completed
- Sponsor
- Oslo University Hospital
- Start
- Sep 2001
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of tobramycin in febrile neutropenia (FN) (2 arms), sponsored by Oslo University Hospital. Primary endpoint: Resolution of fever and signs of infection without modification of the antibiotic regimen. Started Sep 2001; status: completed.
02
Drugs
tobramycin
03
Conditions
febrile neutropenia (FN)
Beyond the preview
Go deeper on NCT00257790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00257790.